Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2014; 20(21): 6602-6607
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6602
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6602
Table 2 Antibiotic use of the study subjects n (%)
| Antibiotics | HD(n =144) | NHD(n =176) | P value |
| Cephalosporin | 128 (88.9) | 119 (67.6) | < 0.01 |
| Aminoglycoside | 96 (66.7) | 34 (19.3) | < 0.01 |
| Quinolone | 99 (68.9) | 63 (35.8) | < 0.01 |
| Carbapenem | 58 (40.3) | 39 (22.2) | < 0.01 |
| Glycopeptide | 43 (29.9) | 47 (26.7) | 0.53 |
| β lactam/β lactamase inhibitor | 40 (27.8) | 82 (46.6) | < 0.01 |
| TMP/SMX | 30 (20.8) | 9 (5.1) | < 0.01 |
| Macrolide | 16 (11.1) | 19 (10.8) | 0.93 |
-
Citation: Gweon TG, Choi MG, Baeg MK, Lim CH, Park JM, Lee IS, Kim SW, Lee DG, Park YJ, Lee JW. Hematologic diseases: High risk of
Clostridium difficile associated diarrhea. World J Gastroenterol 2014; 20(21): 6602-6607 - URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6602.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6602